Genedrive PLC (GDR)
Industry Diagnostics & Research
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.80p
Buy
0.90p
-0.05p (-5.56%)
Prices updated at 17 Dec 2025, 16:29 GMT
| Prices minimum 15 mins delay
Prices in GBX
Genedrive PLC is a holding company engaged in molecular diagnostics business. The company is organised into operating divisions – Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
| 2015 | - |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 6.63 |
| 2024 | 9.26 |
| 2023 | 139.11 |
| 2022 | 190.50 |
| 2021 | 36.92 |
| 2020 | 34.35 |
| 2019 | 2.48 |
| 2018 | 2.03 |
| 2017 | 1.95 |
| 2016 | 2.04 |
| 2015 | 3.34 |
Price/Forward earnings (YTD)
-
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2025 | -108.81 |
| 2024 | -125.14 |
| 2023 | -92.56 |
| 2022 | -81.32 |
| 2021 | -9.01 |
| 2020 | -219.30 |
| 2019 | -55.24 |
| 2018 | -66.47 |
| 2017 | -53.85 |
| 2016 | -42.48 |
| 2015 | -19.77 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2025 | 1.96 |
| 2024 | 1.27 |
| 2023 | 2.21 |
| 2022 | 1.18 |
| 2021 | 1.36 |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | 3.50 |
| 2016 | 3.16 |
| 2015 | 1.68 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
